Published in Vaccine Weekly, September 21st, 2005
Novavax's biological group led by Dr. Gale Smith, together with Dr. Tumpey and Dr. Bu from the U.S. Centers for Disease Control and Prevention (CDC), published the detailed results in the August 15, 2005, online edition of the journal Vaccine. The study demonstrates that a H9N2 influenza virus (avian flu) vaccine produced with the company's proprietary VLP technology is effective in protecting animals when challenged with live H9N2 influenza virus.
The work, published in the peer-reviewed journal Vaccine, was completed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly